Health research policy in the European Union

被引：7

作者：

Saracci, R

Olsen, J

Hofman, A

机构：

[1] CNR, Inst Clin Physiol, Dept Epidemiol, I-56126 Pisa, Italy

[2] Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark

[3] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands

来源：

BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7506期

关键词：

D O I：

10.1136/bmj.330.7506.1459

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：1459 / 1460

页数：2

共 9 条

[1]

[Anonymous], 2004, LANCET, V364, P1911

[2]

[Anonymous], LIFE COUSE APPROACH

[3]

*EUR COMM, EUR RES AR

[4]

*EUR COMM, ESFRI EUR STRAT FOR

[5]

*EUR COMM, EUR RES AR ERC DEB

[6]

*EUR COMM, EUR FUT EUR UN RES P

[7]

FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke [J].

Lenzer, J .

BRITISH MEDICAL JOURNAL, 2005, 330 (7489) :440-440

[8]

Public health and epidemiological research: a blind spot among the European Union priorities? [J].

Saracci, R .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2004, 33 (02) :240-242

[9]

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence [J].

Stampfer, MJ ;

Colditz, GA .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2004, 33 (03) :445-453

← 1 →